rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-2-9
|
pubmed:abstractText |
Few prospective trials in human leukocyte antigen (HLA) identical living donor (LD) renal transplantation exist. This prospective study evaluated a corticosteroid (CS)-free, calcineurin inhibitor (CNI) minimization immunosuppressive regimen in HLA-identical LD renal transplant recipients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1534-6080
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
408-14
|
pubmed:meshHeading |
pubmed-meshheading:19202447-Adrenal Cortex Hormones,
pubmed-meshheading:19202447-Blood Pressure,
pubmed-meshheading:19202447-Cholesterol,
pubmed-meshheading:19202447-Creatinine,
pubmed-meshheading:19202447-Drug Administration Schedule,
pubmed-meshheading:19202447-Drug Therapy, Combination,
pubmed-meshheading:19202447-Follow-Up Studies,
pubmed-meshheading:19202447-Graft Rejection,
pubmed-meshheading:19202447-HLA Antigens,
pubmed-meshheading:19202447-Humans,
pubmed-meshheading:19202447-Immunosuppressive Agents,
pubmed-meshheading:19202447-Kidney Transplantation,
pubmed-meshheading:19202447-Lipoproteins, HDL,
pubmed-meshheading:19202447-Lipoproteins, LDL,
pubmed-meshheading:19202447-Living Donors,
pubmed-meshheading:19202447-Prospective Studies,
pubmed-meshheading:19202447-Retrospective Studies,
pubmed-meshheading:19202447-Time Factors,
pubmed-meshheading:19202447-Triglycerides
|
pubmed:year |
2009
|
pubmed:articleTitle |
A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
|
pubmed:affiliation |
Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH 45267-0585, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|